SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is seeing intense investor conversation following a recent $75 million direct offering that fully funds its Phase 3 MASH trial, coupled with Barclays initiating coverage with an 'Overweight' rating and a $20 price target. The community is actively discussing the potential for a significant rerating, a short squeeze, or even an acquisition, driven by the FDA's Breakthrough Therapy Designation for pemvidutide and its 'best in class' profile in the competitive MASH and weight loss market.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a key player in the ongoing "memory supercycle," driven by significant new investments to expand NAND chip production and strong market signals from the broader semiconductor sector. The community is actively discussing insatiable AI-driven demand and a prolonged supply shortage, leading many to view Micron as fundamentally undervalued despite its rapid ascent. While some express caution regarding the quick rally, prevailing sentiment remains bullish, emphasizing Micron's crucial role in the AI infrastructure buildout.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending with widespread community speculation about an impending major partnership, particularly with Amazon, anticipated to coincide with its upcoming earnings report. This excitement builds on IREN's significant rally, driven by its strategic expansion into high-demand AI infrastructure and data center services, positioning it as a key player in the sector amidst fluctuating market conditions.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is experiencing a surge in attention following its collaboration with Microsoft's AI Co-Innovation Labs, integrating Azure-powered agentic AI into its robotics portfolio. This partnership is driving significant community excitement, with many seeing it as a major validation in the booming AI and robotics sector and anticipating a potential multi-day rally and short squeeze. Despite some calls for caution regarding profit-taking, market sentiment reflects strong bullishness for future growth.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending due to a government proposal for future Medicare Advantage payment rates, which were significantly lower than market expectations, triggering a broad sell-off across the healthcare insurance sector. The community is sharply divided, with many viewing this as an overreaction and a "buy the dip" opportunity, while others anticipate continued pressure on profitability amid regulatory uncertainty. This policy shift has broader implications for the managed care industry's outlook.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

The SPDR Gold Shares ETF (GLD) is trending significantly upward, driven by widespread concerns over dollar weakness and escalating geopolitical risks. The community is actively debating if this constitutes a speculative frenzy or a fundamental shift towards gold as a reliable store of value amidst broader de-dollarization trends and central bank accumulation. This surge reflects a growing market sentiment that precious metals offer a crucial hedge in an uncertain economic landscape.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as it strategically reshapes its physical retail footprint by closing Amazon Go and Fresh stores, signaling a renewed focus on online grocery and Whole Foods. This pivot is sparking community discussion on its retail strategy, while investors also eye its robust AWS division and AI advancements ahead of its anticipated earnings report, with some also noting recent positive analyst sentiment and government contracts.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is actively trending as investors eagerly await its impending earnings report, with community sentiment sharply divided. Bulls anticipate a significant rally driven by recent AI chip innovations, data center expansions, and robotics collaborations, while bears fear a potential sell-off amidst concerns about AI investment returns. The company's performance is widely seen as a crucial indicator for the broader tech sector and the ongoing strength of the AI trade.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings Inc. (VTIX) is a top trending stock following its recent debut on Nasdaq, sparking significant community interest due to extreme intraday volatility and multiple trading halts. Investors are actively discussing its potential for further explosive moves, especially in after-hours trading, driven by its gaming and AI-driven narrative.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. is experiencing a significant surge following robust recent earnings that surpassed expectations, driven by strong enrollment figures across its learning programs. This positive development, coupled with a substantial stock repurchase authorization, is generating considerable community discussion around the company's perceived undervaluation and potential for further upside. Many investors view this as a powerful rebound within the expanding education technology sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seventeen analysts that are covering the company, Marketbeat Ratings...

IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 169.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

IDYA March 20th Options Begin Trading

Investors in IDEAYA Biosciences Inc (Symbol: IDYA) saw new options begin trading today, for the March 20th expiration. One of the key inputs that goes into the price an option buyer is willing to...

IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference PR...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the sixteen analysts that are covering the firm, Marketbeat.com reports. One...

IDEAYA Biosciences Sees Unusually Large Options Volume (NASDAQ:IDYA)

IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors bought 9,011 call options on the stock. This is an increase...

Squarepoint Ops LLC Sells 51,937 Shares of IDEAYA Biosciences, Inc. $IDYA

Squarepoint Ops LLC trimmed its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 58.1% in the second quarter, according to its most recent Form 13F filing with the Securities and...

Redmile Group LLC Sells 102,106 Shares of IDEAYA Biosciences, Inc. $IDYA

Redmile Group LLC reduced its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 19.1% during the 2nd quarter, according to its most recent disclosure with the Securities and...

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal...

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Current Price	$34.74
Prev Close	$34.47
Open	$34.54
Dividend Yield	0.00%
50-Day Moving Average	$34.82
Beta	1.17
Avg. Volume	927,174.95
PE Ratio	-18.72

52-Week High	$39.28
52-Week Low	$13.45
Market Capitalization	$3.02B
EPS (Annual)	-$3.36
Price to Book	2.79
Revenue Per Employee	$53,435.11
Enterprise Value/EBITDA	N/A

IDYA
Ideaya Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IDYA News

IDYAIdeaya Biosciences Inc